Key Points
-
Resistance and tolerance mechanisms govern the infection response and determine host survival
-
A switch to Warburg metabolism seems to be an important survival strategy in immune cells and possibly in tubular epithelial cells in response to inflammation
-
Reprogramming of metabolic pathways is a key cellular strategy to execute resistance and tolerance protective programmes
-
Early metabolic reprogramming in the response to inflammation is crucial to determine the acute response of the cell, to avoid cell death and to determine the repair phenotype during recovery
-
Understanding of resistance and tolerance mechanisms in sepsis might provide a basis for the development of therapeutic strategies to prevent or reverse organ damage, promote recovery and decrease mortality
Abstract
The host defence against infection is an adaptive response in which several mechanisms are deployed to decrease the pathogen load, limit tissue injury and restore homeostasis. In the past few years new evidence has suggested that the ability of the immune system to limit the microbial burden — termed resistance — might not be the only defence mechanism. In fact, the capacity of the host to decrease its own susceptibility to inflammation- induced tissue damage — termed tolerance — might be as important as resistance in determining the outcome of the infection. Metabolic adaptations are central to the function of the cellular immune response. Coordinated reprogramming of metabolic signalling enables cells to execute resistance and tolerance pathways, withstand injury, steer tissue repair and promote organ recovery. During sepsis-induced acute kidney injury, early reprogramming of metabolism can determine the extent of organ dysfunction, progression to fibrosis, and the development of chronic kidney disease. Here we discuss the mechanisms of tolerance that act in the kidney during sepsis, with particular attention to the role of metabolic responses in coordinating these adaptive strategies. We suggest a novel conceptual model of the cellular and organic response to sepsis that might lead to new avenues for targeted, organ-protective therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schneider, D. S. & Ayres, J. S. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8, 889–895 (2008). This opinion article summarizes the evidence for specific tolerance mechanisms in animals and discusses the potential clinical implications of these findings.
Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–810 (2016).
Cheng, S.-C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406–413 (2016).
Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862–874 (2013).
Cohen, J. et al. Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581–614 (2015).
Figueiredo, N. et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 39, 874–884 (2013). This study in a rodent model of sepsis demonstrates that low-dose anthracyclines confer robust protection, independent of bacterial burden, via a mechanism that involves DNA-damage-response-dependent activation of autophagy.
Zager, R. A. 'Biologic memory' in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease. Nephrol. Dial. Transplant. 28, 1985–1993 (2013). This experimental study demonstrates that ischaemic or toxic renal injury triggers cellular adaptations that reprogramme the response of the kidney to subsequent injury.
Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813–818 (2005).
Thakar, C. V., Yared, J.-P., Worley, S., Cotman, K. & Paganini, E. P. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 64, 239–246 (2003).
Murugan, R. & Kellum, J. A. Acute kidney injury: what's the prognosis? Nat. Rev. Nephrol. 7, 209–217 (2011).
Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936–941 (2012). This review summarizes the host defence against infection and discusses the integral role of tolerance in this response.
Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343–353 (2015).
Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
El-Achkar, T. M. et al. Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am. J. Physiol. Renal Physiol. 290, F1034–F1043 (2006).
El-Achkar, T. M., Hosein, M. & Dagher, P. C. Pathways of renal injury in systemic gram-negative sepsis. Eur. J. Clin. Invest. 38, 39–44 (2008).
Kalakeche, R. et al. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J. Am. Soc. Nephrol. 22, 1505–1516 (2011). This study demonstrates that LPS can be filtered through the glomerulus, tubular epithelial cells can bind LPS through TLR4, and uptake of LPS by S1 tubular epithelial cells triggers a coordinated response characterized by oxidative stress in neighbouring cells in the S2 and S3 segments of the nephron.
Naito, M., Bomsztyk, K. & Zager, R. A. Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J. Am. Soc. Nephrol. 19, 1321–1330 (2008).
Murugan, R. et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol. Dial. Transplant. 29, 1854–1864 (2014).
Schafer, J. F. Tolerance to plant disease. Annu. Rev. Phytopathol. 9, 235–252 (1971). This review describes the importance of tolerance mechanisms in plants.
Larsen, R. et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl Med. 2, 51ra71 (2010). This experimental study demonstrates that free haemoglobin induces substantial organ injury during murine sepsis, and that activation of haem-oxygenase-1 or administration of haemopexin confers protection against organ injury and a survival advantage by increasing tolerance.
Råberg, L., Sim, D. & Read, A. F. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318, 812–814 (2007). The first study to demonstrate tolerance mechanisms in mammals using a model of murine malaria and a statistical framework developed by plant ecologists.
Ferreira, A., Balla, J., Jeney, V., Balla, G. & Soares, M. P. A central role for free heme in the pathogenesis of severe malaria: the missing link? J. Mol. Med. 86, 1097–1111 (2008).
Hsiao, H.-W. et al. The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 37, 289–296 (2012).
Bartz, R. R. et al. Staphylococcus aureus sepsis induces early renal mitochondrial DNA repair and mitochondrial biogenesis in mice. PLoS ONE 9, e100912 (2014).
Takasu, O. et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am. J. Respir. Crit. Care Med. 187, 509–517 (2013).
Hallows, K. R., Mount, P. F., Pastor-Soler, N. M. & Power, D. A. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am. J. Physiol. Renal Physiol. 298, F1067–F1077 (2010).
Escobar, D. A. et al. Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation. J. Surg. Res. 194, 262–272 (2015).
Howell, G. M. et al. Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS ONE 8, e69520 (2013).
Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769–777 (2002). Experimental study that demonstrates that the metabolic phenotype of activated T cells is aerobic glycolysis, and that CD28 co-stimulation through the PI3K/Akt pathway is required to increase glycolytic flux in this context.
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
Smith, J. A., Stallons, L. J. & Schnellmann, R. G. Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 307, F435–F444 (2014).
Waltz, P., Carchman, E., Gomez, H. & Zuckerbraun, B. Sepsis results in an altered renal metabolic and osmolyte profile. J. Surg. Res. 202, 8–12 (2016).
Patil, N. K., Parajuli, N., MacMillan-Crow, L. A. & Mayeux, P. R. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury. Am. J. Physiol. Renal Physiol. 306, F734–F743 (2014).
Tran, M. et al. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Invest. 121, 4003–4014 (2011).
Jin, K. et al. Is acute kidney injury in the early phase of sepsis a sign of metabolic downregulation in tubular epithelial cells? Crit. Care 19 (Suppl. 1), P286 (2015).
Faubert, B. et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17, 113–124 (2013). This experimental study demonstrates that AMPK negatively regulates aerobic glycolysis in cancer cells, and that inactivation of the AMPKα catalytic subunit promotes a metabolic shift to aerobic glycolysis, which requires HIF-1α stabilization.
Hudson, C. C. et al. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22, 7004–7014 (2002).
Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R. & Tee, A. R. mTORC1 drives HIF-1α; and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34, 2239–2250 (2014).
Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014). This study demonstrates that a shift of central glucose metabolism from oxidative phosphorylation to aerobic glycolysis is the metabolic basis for trained immunity.
Yang, L. et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436 (2014). This experimental study demonstrates that pyruvate kinase M2 interacts with HIF-1α to induce aerobic glycolysis (Warburg effect) in macrophages, and that PKM2 is a key regulator of the release of high mobility group box 1 during sepsis and inflammation.
O'Neill, L. A. J. & Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346–355 (2013).
Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742–4749 (2010).
Jiang, L. & DeBerardinis, R. J. Cancer metabolism: when more is less. Nature 489, 511–512 (2012).
Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732–744 (2011).
Opal, S. et al. Sirt1 activation markedly alters transcription profiles and improves outcome in experimental sepsis. Shock http://dx.doi.org/10.1097/SHK.0000000000000528 (2015).
Vachharajani, V. T. et al. SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. J. Leukoc. Biol. 96, 785–796 (2014).
Gomez, H. et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 41, 3–11 (2014).
Patra, K. C. & Hay, N. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39, 347–354 (2014).
Jeon, S.-M., Chandel, N. S. & Hay, N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485, 661–665 (2013).
Tran, M. T. et al. PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531, 528–532 (2016).
Brealey, D. et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R491–R497 (2004).
Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).
Sayeed, M. M., Zhu, M. & Maitra, S. R. Alterations in cellular calcium and magnesium during circulatory/septic shock. Magnesium 8, 179–189 (1989).
Duchen, M. R., Verkhratsky, A. & Muallem, S. Mitochondria and calcium in health and disease. Cell Calcium 44, 1–5 (2008).
Haden, D. W. et al. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 176, 768–777 (2007).
Hotchkiss, R. S., Strasser, A., McDunn, J. E. & Swanson, P. E. Cell death. N. Engl. J. Med. 361, 1570–1583 (2009).
Carchman, E. H., Rao, J., Loughran, P. A., Rosengart, M. R. & Zuckerbraun, B. S. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 53, 2053–2062 (2011).
Scarpulla, R. C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813, 1269–1278 (2011).
Carchman, E. H. et al. Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver. FASEB J. 27, 4703–4711 (2013).
Zager, R. A., Johnson, A. C. M., Hanson, S. Y. & Lund, S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am. J. Physiol. Renal Physiol. 289, F289–F297 (2005).
Zager, R. A., Johnson, A. C. M., Hanson, S. Y. & Lund, S. Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/chemokine production. Kidney Int. 69, 1181–1188 (2006).
Han, S. H. et al. Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J. Am. Soc. Nephrol. 27, 439–453 (2016). This experimental study demonstrates a role of Lkb1 (a master regulator of metabolism) in the progression from AKI to CKD.
Liu, T. F., Vachharajani, V. T., Yoza, B. K. & McCall, C. E. NAD+-dependent Sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J. Biol. Chem. 287, 25758–25769 (2012). This experimental study demonstrates the roles of Sirt1 and Sirt6 in the metabolic switch from aerobic glycolysis to oxidative phosphorylation in THP-1 promonocytes during the acute inflammatory response.
Zhong, L. & Mostoslavsky, R. SIRT6: a master epigenetic gatekeeper of glucose metabolism. Transcription 1, 17–21 (2014).
Vega, R. B., Huss, J. M. & Kelly, D. P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20, 1868–1876 (2000).
Lehman, J. J. et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106, 847–856 (2000).
Kellum, J. A. et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am. J. Respir. Crit. Care Med. 193, 281–287 (2016).
Kellum, J. A. et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch. Intern. Med. 167, 1655–1663 (2007).
Zager, R. A., Johnson, A. C. M. & Becker, K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and 'end-stage' kidney disease. Am. J. Physiol. Renal Physiol. 301, F1334–F1345 (2011).
Grgic, I. et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82, 172–183 (2012).
Heung, M. & Chawla, L. S. Predicting progression to chronic kidney disease after recovery from acute kidney injury. Curr. Opin. Nephrol. Hypertens. 21, 628–634 (2012).
Basile, D. P. et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J. Am. Soc. Nephrol. 27, 687–697 (2016).
Hodgkins, K. S. & Schnaper, H. W. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr. Nephrol. 27, 901–909 (2011).
Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37–46 (2015). This study demonstrates that human and murine kidneys with tubulointerstitial fibrosis have reduced expression of enzymes involved in fatty acid oxidation, and that inhibition of these enzymes in a murine model results in renal fibrosis, which can be reversed by restoring fatty acid metabolism.
Qiu, S. et al. AMPKα2 reduces renal epithelial transdifferentiation and inflammation after injury through interaction with CK2β. J. Pathol. 237, 330–342 (2015).
Bihorac, A. et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am. J. Respir. Crit. Care Med. 189, 932–939 (2014).
Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care 17, R25 (2013).
Sharma, A., Mucino, M. J. & Ronco, C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin. Pract. 127, 94–100 (2014).
Liu, K. D. & Brakeman, P. R. Renal repair and recovery. Crit. Care Med. 36, S187–S192 (2008).
Fliser, D., Zeier, M., Nowack, R. & Ritz, E. Renal functional reserve in healthy elderly subjects. J. Am. Soc. Nephrol. 3, 1371–1377 (1993).
Acknowledgements
H.G. is supported by NIH grants 1K12HL109068-02 and 1K08GM117310-01A1.
Author information
Authors and Affiliations
Contributions
All authors researched the data, discussed the content, wrote the article and reviewed or edited the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
J.A.K. has received consulting fees and grant support from Astute Medical. H.G. and C.R. declare no competing interests.
Glossary
- Warburg effect
-
A coordinated change in cellular metabolism from oxidative phosphorylation to glycolysis to support the production of ATP and essential structural components required by the cell. This switch in metabolism can occur even in aerobic conditions.
- Autophagy
-
An intracellular degradation pathway in which cellular components are taken up by autophagosomes and transported to lysosomes for degradation and recycling.
- Oxidative phosphorylation
-
A metabolic process in which electrons derived from oxidation of carbon fuels (such as glucose and fats) are transported through electron acceptors and donors in the inner mitochondrial membrane. This process releases the energy required to generate adenosine triphosphate in the presence of oxygen.
- Tricarboxylic acid cycle
-
A series of enzyme-catalysed reactions that through oxidation of acetyl-coenzyme A (derived from carbohydrate, fat and protein), yields reducing equivalents such as NADH, which are necessary for many processes including ATP generation.
- Mitophagy
-
A specialized form of autophagy that targets and degrades dysfunctional mitochondria.
- Biogenesis
-
Mitochondrial biogenesis is a coordinated process that involves both nuclear and mitochondrial DNA and results in the regeneration of new mitochondria.
- Epithelial-to-mesenchymal transition
-
In the context of organ injury, epithelial-to-mesenchymal transition refers to the process by which epithelial cells undergo a transition to myofibroblasts, which produce collagenous matrix and promote tissue fibrosis.
Rights and permissions
About this article
Cite this article
Gómez, H., Kellum, J. & Ronco, C. Metabolic reprogramming and tolerance during sepsis-induced AKI. Nat Rev Nephrol 13, 143–151 (2017). https://doi.org/10.1038/nrneph.2016.186
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2016.186
This article is cited by
-
Discovery and verification of mmu_Circ_26986/hsa_Circ_0072463 as a potential biomarker and intervention target for sepsis-associated acute kidney injury
Cellular and Molecular Life Sciences (2024)
-
Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study)
Digestive Diseases and Sciences (2024)
-
The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
Cell Death & Disease (2023)
-
Sepsis-Associated Acute Kidney Injury
Intensive Care Research (2023)
-
Decreased renal cortical perfusion, independent of changes in renal blood flow and sublingual microcirculatory impairment, is associated with the severity of acute kidney injury in patients with septic shock
Critical Care (2022)